Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06IJW
|
|||
Former ID |
DNC007837
|
|||
Drug Name |
1-(4-hexylphenyl)-3-morpholinopropan-1-one
|
|||
Synonyms |
beta-Aminophenylketone, 3e; CHEMBL236132; BDBM18818; AKOS022274318
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C19H29NO2
|
|||
Canonical SMILES |
CCCCCCC1=CC=C(C=C1)C(=O)CCN2CCOCC2
|
|||
InChI |
1S/C19H29NO2/c1-2-3-4-5-6-17-7-9-18(10-8-17)19(21)11-12-20-13-15-22-16-14-20/h7-10H,2-6,11-16H2,1H3
|
|||
InChIKey |
DRNLQHKMQJOYPM-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Thyroid hormone receptor alpha (THRA) | Target Info | Inhibitor | [1] |
Thyroid hormone receptor beta (THRB) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Thyroid hormone signaling pathway | ||||
Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | |||
Reactome | Nuclear Receptor transcription pathway | |||
WikiPathways | Endochondral Ossification | |||
Nuclear Receptors | ||||
SIDS Susceptibility Pathways | ||||
Hematopoietic Stem Cell Differentiation |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships. J Med Chem. 2007 Nov 1;50(22):5269-80. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.